GO
Loading...

Video and TV

More

Art Cashin, UBS director of floor operations, discusses indecisiveness in Thursday's equity markets and what investors need to watch to gauge geopolitical rumors.

CNBC's Rick Santelli discusses sustainability in the stock market and the direction of the U.S. economy.

Sticking to your retirement goals     Thu, 24 Apr '14 | 11:00 AM ET

How do you cut through the clutter of all of the financial advice out there and stick your retirement plans?

$1.25 million 'inked up' Aston Martin     Thu, 24 Apr '14 | 10:55 AM ET

A 2002 Aston Martin Vanquish has been signed by 50 NBA Hall of Fame players. CNBC's Robert Frank reports the car has been appraised at $1.25 million.

CNBC's Jeff Cox discusses the future of Wall Street as well as whether or not New York will remain the financial capital of the world.

Cramer's stocks to watch: CAT     Thu, 24 Apr '14 | 8:49 AM ET

Today CNBC's Jim Cramer explains why he wishes his charitable trust owned shares of Caterpillar, and shares his thoughts on the government's inability to create jobs.

Facebook is an ad sales company: Pro     Thu, 24 Apr '14 | 8:19 AM ET

Daniel Ernst, Hudson Square Research, weighs in on the departure of Facebook's CFO and the company's evolving identity.

CAT CEO: Global outlook a mixed bag     Thu, 24 Apr '14 | 8:02 AM ET

Doug Oberhelman, Caterpillar chairman & CEO, digs deep into the company's first quarter results and shares his outlook on global sales. CAT reported EPS of $1.44 on revenues of $13.24 billion, beating on both the top and bottom line.

I think this is going to be the corporate story of the year, says Austan Goolsbee, 32 Advisors strategic partner, discussing how the tech giant is likely to spend its cash.

Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.

Discussing Apple's 7-for-1 stock split effective June 9, and the company's bad tablet number, with Max Wolff, Citizen VC chief economist, and Gene Munster, Piper Jaffray senior research analyst.

CNBC's Becky Quick speaks with Warren Buffett about why he abstained in his vote on Coke shareholder equity plan. The package was excessive, he says.

Carl Icahn's take on Ackman & Valeant     Wed, 23 Apr '14 | 9:19 AM ET

Activist investor Carl Icahn comments on Bill Ackman's role in the Valeant Pharmaceuticals bid for Allergan. The "Squawk on the Street" team provide insight.

Cramer: Can't lose if you're Ackman     Wed, 23 Apr '14 | 9:17 AM ET

The "Squawk on the Street" news team discuss the involvement of Bill Ackman in the deal between Valeant Pharmaceuticals and Allergan.

William Ackman, Pershing Square Capital Management, explains how his partnership with Valeant is structured. And J. Michael Pearson, Valeant chairman & CEO, discusses why he partnered with Ackman instead of pursing Allergan alone. Creating shareholder value is our job, says Pearson.

It's not a dirty little secret anymore, says Heather Thomson, Yummie by Heather Thomson founder, discussing how her company is redefining the shapewear industry and carving out a piece of the market.

Who will win Aereo case?     Tue, 22 Apr '14 | 1:19 PM ET

Porter Bibb, MediaTech Capital Partners, shares his thoughts on the likely outcome of the Aereo case and who will be the winners and losers.

How to play big pharma     Tue, 22 Apr '14 | 1:10 PM ET

Barbara Ryan, CNBC contributor, shares an inside look at what's happening among the drug giants as billion dollar deals are announced and big player reshape the industry.

Gasoline hits 8-month high     Tue, 22 Apr '14 | 12:33 PM ET

The Futures Now team discusses what's likely driving the increase in gasoline prices.

Meb Keflezighi, the first American man to win the Boston Marathon since 1983, explains what ended his sneaker deal with Nike three years ago.

CNBC's Mary Thompson and Art Cashin, of UBS, discuss the S&P 500 nearing its next resistance level, and the potential it breaks through to an all-time high.

CNBC's David Faber speaks with activist investor Ralph Whitworth, Relational Investors founder and principal, about his relationship with the management team at Mondelez and the opportunity he sees in SPX Corp.

Tesla delivers Model S to China     Tue, 22 Apr '14 | 11:24 AM ET

The Tesla Model S is now available in China. CNBC's Phil LeBeau expects sales for the electric car to ramp up very quickly.

Mossberg on Apple's 'movie studio' model     Tue, 22 Apr '14 | 11:16 AM ET

Walter Mossberg, Re/Code co-executive editor, breaks down Apple's product cycle and compares the tech giant's reprocessing of products to a movie studio.

Beijing Auto Show     Tue, 22 Apr '14 | 11:00 AM ET

American automakers are investing heavily in China, the world's fastest growing car market.

Cramer's favorite marijuana stock     Tue, 22 Apr '14 | 9:55 AM ET

CNBC's Jim Cramer explains why he is watching cannabis stock GW Pharma.

Close look at Allergan bid     Tue, 22 Apr '14 | 9:01 AM ET

The "Squawk on the Street" news team discuss the legality of activist investor Bill Ackman backing the bid of Valeant Pharmaceuticals to acquire Allergan.

USDA: Chances of El Nino now 50-67%     Tue, 22 Apr '14 | 8:42 AM ET

CNBC's Jane Wells reports on the good and bad of El Nino if it develops near South American mines, and coffee and cocoa.

Five generations after it was founded, Leinenkugel Brewing Company is still run by the family and trying to help those who just can't pronounce the name.

Ackman & Valeant's bid for Allergan     Tue, 22 Apr '14 | 7:04 AM ET

In an SEC Filing, Valeant Pharmaceuticals said it expected to offer a mix of stock and about $15 billion in cash for botox maker Allergan. David Krempa, Morningstar equity analyst, and CNBC's Meg Tirrell, provide perspective.

Contact Video and TV

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

U.S. Video

Asia Video

Europe Video

Most Popular Video

Thursday, 24 Apr 2014 | 12:00 PM ET

CNBC's Ted Kemp discusses how it's not just the legal transactions of the world that support the dollar as a reserve currency, but the illegal ones such as guns and drugs.

Thursday, 24 Apr 2014 | 11:53 AM ET

Art Cashin, UBS director of floor operations, discusses indecisiveness in Thursday's equity markets and what investors need to watch to gauge geopolitical rumors.

Thursday, 24 Apr 2014 | 10:30 AM ET

Russia's defense minister announces new military exercises, reports CNBC's Michelle Caruso-Cabrera on events taking place in Eastern Ukraine.